Design, synthesis, and evaluation of methoxylated resveratrol derivatives as potential antitumor agents
Authors:
- 15 September 2013
- journal article
- research article
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 41 (5) , 2725-2738
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant MiceCancer Cell, 2008
- Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative DiseasesCNS Neuroscience & Therapeutics, 2008
- Antitumor activity of 3,5,4′‐trimethoxystilbene in COLO 205 cells and xenografts in SCID miceMolecular Carcinogenesis, 2007
- Inhibition of swarming and virulence factor expression in Proteus mirabilis by resveratrolJournal of Medical Microbiology, 2006
- Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4′‐tetramethoxystilbene (DMU‐212) on adenoma development in the ApcMin+ mouse and cyclooxygenase‐2 in human‐derived colon cancer cellsInternational Journal of Cancer, 2005
- Sirtuin activators mimic caloric restriction and delay ageing in metazoansNature, 2004
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003
- Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expressionCarcinogenesis, 2000
- Synthesis and Nematocidal Activity of HydroxystilbenesChemical and Pharmaceutical Bulletin, 1992
- Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism.Chemical and Pharmaceutical Bulletin, 1982